☰

Soma Sengupta - Publications

Affiliations: 
Neurology University of Cincinnati, Cincinnati, OH 
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bhattacharya D, Pomeroy SL, Pomeranz Krummel DA, Sengupta S. Epigenetics and survivorship in pediatric brain tumor patients. Journal of Neuro-Oncology. PMID 32451770 DOI: 10.1007/S11060-020-03535-3  0.599
2020 Pomeranz Krummel DA, Nasti TH, Izar B, Press RH, Xu M, Lowder L, Kallay L, Rupji M, Rosen H, Su J, Curran W, Olson J, Weinberg B, Schniederjan M, Neill S, ... ... Sengupta S, et al. Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases. International Journal of Radiation Oncology, Biology, Physics. PMID 32057994 DOI: 10.1016/J.Ijrobp.2020.01.043  0.308
2020 Chakraborty S, Dlie ZY, Mukherjee B, Besra SE, Sengupta S, Sen R, Mukherjee A. A Comparative Investigation of the Ability of Various Aptamer-Functionalized Drug Nanocarriers to Induce Selective Apoptosis in Neoplastic Hepatocytes: In Vitro and In Vivo Outcome. Aaps Pharmscitech. 21: 89. PMID 32026264 DOI: 10.1208/S12249-020-1629-Z  0.327
2020 Bhattacharya D, Krummel DP, Sengupta S. Pediatric cerebellar tumors: transcriptionally distinct but developmentally heterogeneous Translational Cancer Research. 9: 1322-1325. DOI: 10.21037/Tcr.2020.01.31  0.363
2019 Cicka D, Ford CL, Templin E, Pitts Z, Gurbani S, Eaton B, Lowder L, Olson J, Weinberg BD, Shim H, Sengupta S. Presentation of treatment effect in glioblastoma after dose-escalation radiation therapy. Oxford Medical Case Reports. 2019: omz085. PMID 31772751 DOI: 10.1093/Omcr/Omz085  0.306
2019 Kallay L, Keskin H, Ross A, Rupji M, Moody OA, Wang X, Li G, Ahmed T, Rashid F, Stephen MR, Cottrill KA, Nuckols TA, Xu M, Martinson DE, Tranghese F, ... ... Sengupta S, et al. Modulating native GABA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death. Journal of Neuro-Oncology. PMID 30725256 DOI: 10.1007/S11060-019-03115-0  0.401
2019 Kallay L, Keskin H, Ross A, Rupji M, Moody OA, Wang X, Li G, Ahmed T, Rashid F, Stephen MR, Cottrill KA, Nuckois A, Xu M, Martinson DE, Tranghese F, ... ... Sengupta S, et al. Abstract 2623: Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death Cancer Research. 79: 2623-2623. DOI: 10.1158/1538-7445.Am2019-2623  0.42
2019 Burnhamm A, Kaluzova M, Kallay L, Li G, Ahmed T, Rashid F, Jenkins A, Cook J, Krummel DP, Sengupta S. Abstract 255: Antagonizing Na-K-Cl cotransporter NKCC1 impairs medulloblastoma cell viability Cancer Research. 79: 255-255. DOI: 10.1158/1538-7445.Am2019-255  0.397
2019 Kaluzova M, Nasti T, Chen H, Lowder L, Press R, Rosen H, Rupji M, Kallay L, Patel R, Burnham A, Xu M, Ross A, Keskin H, Connelly E, Izar B, ... ... Sengupta S, et al. Abstract 247: Identification of the GABAAreceptor in melanoma brain metastases patient tumors and demonstration that it is a viable drug target using benzodiazepine-derivatives Cancer Research. 79: 247-247. DOI: 10.1158/1538-7445.Am2019-247  0.437
2019 Pomeranz Krummel D, Nasti T, Izar B, Xu M, Lowder L, Press R, Kaluzova M, Kallay L, Rupji M, Burnham A, Li G, Ahmed T, Rosen H, Connolly E, Keskin H, ... ... Sengupta S, et al. EXTH-12. RADIATION ENHANCES MELANOMA RESPONSE TO IMMUNOTHERAPY AND SYNERGIZES WITH BENZODIAZEPINES TO PROMOTE ANTI-TUMOR ACTIVITY Neuro-Oncology. 21: vi84-vi84. DOI: 10.1093/Neuonc/Noz175.346  0.439
2018 Doyle SP, Gurbani SS, Ross AS, Rosen H, Barrett CD, Olson JJ, Shim H, Shu HK, Sengupta S. The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma. Oxford Medical Case Reports. 2018: omy095. PMID 30410775 DOI: 10.1093/Omcr/Omy095  0.339
2018 Clark AR, Calligaris D, Regan MS, Pomeranz Krummel D, Agar JN, Kallay L, MacDonald T, Schniederjan M, Santagata S, Pomeroy SL, Agar NYR, Sengupta S. Rapid discrimination of pediatric brain tumors by mass spectrometry imaging. Journal of Neuro-Oncology. PMID 30128689 DOI: 10.1007/S11060-018-2978-2  0.59
2018 Melms JC, Ho KW, Thummalapalli R, Tyler J, Brinker TJ, Singh V, Sengupta S, Mier J, Izar B. Implementation of cell-free tumor DNA sequencing from the cerebrospinal fluid to guide treatment in a patient with primary leptomeningeal melanoma: A case report. Molecular and Clinical Oncology. 9: 58-61. PMID 29977540 DOI: 10.3892/Mco.2018.1621  0.347
2018 Archer TC, Sengupta S, Pomeroy SL. Brain cancer genomics and epigenomics. Handbook of Clinical Neurology. 148: 785-797. PMID 29478614 DOI: 10.1016/B978-0-444-64076-5.00050-8  0.698
2018 Kallay L, Keskin H, Ross A, Moody O, Cottrill K, Nuckols A, Li G, Ahmed T, Rashid F, Stephen M, Xu M, Martinson D, Macdonald T, Kowalski J, Wang X, ... ... Sengupta S, et al. PDTM-45. POSITIVE MODULATION OF NATIVE GABAA RECEPTORS IN MEDULLOBLASTOMA CANCER CELLS WITH BENZODIAZEPINES INDUCES RAPID MITOCHONDRIAL FRAGMENTATION AND TP53-DEPENDENT, CELL CYCLE-INDEPENDENT APOPTOSIS Neuro-Oncology. 20: vi213-vi213. DOI: 10.1093/Neuonc/Noy148.884  0.309
2017 Sengupta S, Pomeranz Krummel D, Pomeroy S. The evolution of medulloblastoma therapy to personalized medicine. F1000research. 6: 490. PMID 28713553 DOI: 10.12688/F1000Research.10859.1  0.583
2017 Calligaris D, Clark A, Kallay L, Krummel DP, Agar J, Schniederjan M, Pomeroy S, Agar NY, Sengupta S. PATH-04. DISTINGUISHING PINEOBLASTOMA FROM MEDULLOBLASTOMAS USING TISSUE MASS SPECTROMETRY IMAGING Neuro-Oncology. 19: vi171-vi171. DOI: 10.1093/Neuonc/Nox168.695  0.472
2016 Jonas O, Calligaris D, Methuku KR, Poe MM, Francois JP, Tranghese F, Changelian A, Sieghart W, Ernst M, Krummel DA, Cook JM, Pomeroy SL, Cima M, Agar NY, Langer R, ... Sengupta S, et al. First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development. Journal of Biomedical Nanotechnology. 12: 1297-302. PMID 27319222 DOI: 10.1166/Jbn.2016.2262  0.587
2015 Ippen FM, Mahadevan A, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM. Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection. Journal of Oncology. 2015: 636918. PMID 26681942 DOI: 10.1155/2015/636918  0.303
2014 Sengupta S, Weeraratne SD, Cho YJ, Pomeroy SL. Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas? Cns Oncology. 3: 245-7. PMID 25286034 DOI: 10.2217/Cns.14.27  0.743
2014 Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N, Kosaras B, Amani V, Pierre-Francois J, Tang Y, Nguyen B, Yu F, Schubert S, Balansay B, Mathios D, et al. α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. Acta Neuropathologica. 127: 593-603. PMID 24196163 DOI: 10.1007/S00401-013-1205-7  0.727
2014 Jonas O, Sengupta S, Calligaris D, Poe M, Methuku K, Francois JP, Cook J, Agar N, Pomeroy S, Langer R. ET-24 * A NOVEL TROJAN HORSE FOR IN-VIVO SENSITIVITY TESTING OF MEDULLOBLASTOMA THERAPIES Neuro-Oncology. 16: v84-v84. DOI: 10.1093/Neuonc/Nou255.24  0.624
2012 Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, ... ... Sengupta S, et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature. 488: 106-10. PMID 22820256 DOI: 10.1038/Nature11329  0.687
2012 Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, Kye MJ, Sengupta S, Archer T, Remke M, Bai AH, Warren P, Pfister SM, Steen JA, Pomeroy SL, Cho YJ. Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathologica. 123: 539-52. PMID 22402744 DOI: 10.1007/S00401-012-0969-5  0.679
2011 Pavel H, Ajeawung N, Faure R, Poirier D, Kamnasaran D, Ajeawung N, Joshi H, Kamnasaran D, Poirier D, Ajeawung N, Kamnasaran D, Lun X, Zemp F, Sun B, Stechishin O, ... ... Sengupta S, et al. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 13: iii107-iii120. DOI: 10.1093/Neuonc/Nor158  0.708
Show low-probability matches.